Abstract
Purpose: Hepatitis C virus (HCV) cases have increased in the past decade, with many cases in pregnant patients. However, recommendations for HCV screening during pregnancy vary by professional organization. Methods: Prenatal care providers were surveyed via e-mail about factors affecting choice of HCV screening. Findings: A total of 86 completed surveys were received. Providers using risk-based screening valued guidance from obstetrics and gynecology societies and risk for vertical transmission. Providers using universal screening valued availability of curative treatment in addition to guidance from the Centers for Disease Control and Prevention/infectious diseases societies and obstetrics and gynecology societies. Implications: The results highlight the need for consensus guidelines on HCV screening as a part of prenatal care.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 780-784 |
| Number of pages | 5 |
| Journal | Clinical Therapeutics |
| Volume | 43 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2021 |
Funding
R.J. has served as a member of the AASLD/IDSA HCV Guidance Panel, and has received funding for research/clinical trials work from AbbVie, Gilead, and Merck. The authors have indicated that they have no conflicts of interest with regard to the content of this article. EG: designed and distruted survey, analyzed data and drafted initial manuscript. RJ: conceived study idea, reviewed survey content and data summary, edited manuscript.
Keywords
- guidelines
- hepatitis C virus
- pregnancy
- screening
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
